These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2970949

  • 21. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
    Mini E, Mazzei T, Reali EF, Novelli A, Periti P.
    Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses.
    Del Favero A, Patoia L, Rosina R, Buniva G, Danese A, Bernareggi A, Molini E, Cavenaghi L.
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2551-7. PubMed ID: 1839759
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment.
    Domart Y, Pierre C, Clair B, Garaud JJ, Regnier B, Gibert C.
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1600-4. PubMed ID: 2963586
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers.
    Carver PL, Nightingale CH, Quintiliani R, Sweeney K, Stevens RC, Maderazo E.
    Antimicrob Agents Chemother; 1989 Jan; 33(1):82-6. PubMed ID: 2523689
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics and bioavailability of piretanide in healthy volunteers following intramuscular administration.
    Trenk D, Wagner F, Jähnchen E, Spahn H, Mutschler E.
    Arzneimittelforschung; 1987 Dec; 37(12):1382-5. PubMed ID: 3449067
    [Abstract] [Full Text] [Related]

  • 26. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L, Rowland M, Khan A, Taborelli G, Ferrea G, Tarantino V, Fioredda F, Rosina-Parenti R, Cavenaghi L, Borgonovi M.
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [Abstract] [Full Text] [Related]

  • 27. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses.
    Outman WR, Nightingale CH, Sweeney KR, Quintiliani R.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB, Wu WX, Su D, Wang ZJ, Jiang HY, Shen JZ.
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics and renal clearance of oxytetracycline after intravenous and intramuscular administration to dairy cows.
    Nouws JF, Vree TB, Termond E, Lohuis J, van Lith P, Binkhorst GJ, Breukink HJ.
    Vet Q; 1985 Oct; 7(4):296-305. PubMed ID: 4071950
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of teicoplanin in children.
    Tarral E, Jehl F, Tarral A, Simeoni U, Monteil H, Willard D, Geisert J.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():47-51. PubMed ID: 2965131
    [Abstract] [Full Text] [Related]

  • 31. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.
    Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, Kenny MT, Yuh L.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):696-700. PubMed ID: 1829880
    [Abstract] [Full Text] [Related]

  • 32. Teicoplanin population pharmacokinetic analysis in hospitalized patients.
    Soy D, López E, Ribas J.
    Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688
    [Abstract] [Full Text] [Related]

  • 33. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.
    ismail M.
    Vet Res Commun; 2007 May; 31(4):467-76. PubMed ID: 17216308
    [Abstract] [Full Text] [Related]

  • 34. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
    Bernareggi A, Borgonovi M, Del Favero A, Rosina R, Gavanaghi L.
    Eur J Drug Metab Pharmacokinet; 1991 May; Spec No 3():256-60. PubMed ID: 1840325
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose.
    Bernareggi A, Cavenaghi L, Assandri A.
    Antimicrob Agents Chemother; 1986 Nov; 30(5):733-8. PubMed ID: 2948443
    [Abstract] [Full Text] [Related]

  • 36. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J, Loft S, Døssing M, Vollmer-Larsen A, Olesen KL, Victor M, Andreasen F, Andreasen PB.
    Eur J Clin Pharmacol; 1988 Nov; 35(4):385-9. PubMed ID: 3197746
    [Abstract] [Full Text] [Related]

  • 37. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
    Filippos'iants ST, Malkova IV, Gol'dberg LE.
    Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus).
    Abu-Basha EA, Gehring R, Hantash TM, Al-Shunnaq AF, Idkaidek NM.
    J Vet Pharmacol Ther; 2009 Jun; 32(3):258-63. PubMed ID: 19646090
    [Abstract] [Full Text] [Related]

  • 39. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA, Daoud SS.
    Anticancer Res; 2001 Jun; 21(6A):4005-10. PubMed ID: 11911284
    [Abstract] [Full Text] [Related]

  • 40. Single-dose pharmacokinetics of 3-O-demethylfortimicin A in humans after intravenous and intramuscular administration.
    Sennello LT, Wilson DS, Afarian J, Holtam LS, Norman G, Rollins DE, Tolman KG.
    Antimicrob Agents Chemother; 1986 Mar; 29(3):400-4. PubMed ID: 3717941
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.